NATR earnings analysis
What we found in NATR's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Nature's Sunshine Products, Inc. reported solid financial performance in Q1 2026, with net sales increasing 8.5% year-over-year to $122.9 million and diluted EPS rising to $0.3, exceeding expectations. In addition, both gross and operating margins improved, reflecting effective cost management and operational efficiencies, although cash flows from operations turned negative this quarter due to timing issues.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Growth of 8.5% YOY
- Net sales for Q1 2026 reached $122.9 million, up from $113.2 million in Q1 2025.
- EPS Beats Estimates
- Diluted EPS for Q1 2026 was $0.3, surpassing the estimate of $0.2.
- Improved Gross Margin
- Gross margin increased to 73.2%, up from 72.1% in the same quarter last year.
- Strong Segment Performance
- Latin America and Europe saw net sales increase of approximately 9.7% and 9.5% YOY, respectively.
- Operating Income Increase
- Operating income rose to $9.5 million for the quarter, a 54.7% increase from $6.2 million in Q1 2025.
- Maintained Strong Cash Position
- End of period cash and cash equivalents stood at $87.6 million, up from $85.9 million as of December 31, 2025.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Decline in Asia Market
- Net sales in Taiwan decreased by $2.9 million or 16.1%, suggesting challenges in that market.
- Increased SG&A Expenses
- Selling, general and administrative expenses increased by $3.0 million to $43.5 million compared to Q1 2025.
- Foreign Exchange Exposure
- Ongoing geopolitical tensions continue to pose risks related to foreign currency fluctuations affecting operations.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.3
- Gross margin
- 73.2%
- Operating margin
- 7.8%
- Segment
- Asia: $52.183M
- Segment
- Europe: $26.395M
- Segment
- North America: $38.323M
- Segment
- Latin America: $5.991M
What they said about what is next.
Qualitative outlook discusses continued growth but lacks specific numeric guidance.
The filing reads better than the one before it.
What came before.
- 10-K · March 10, 2026
- Nature’s Sunshine reported multi-quarter momentum that produced higher full-year results: consolidated revenue rose to $480.0 million in 2025 vs $455.0 million in 2024 (sum of quarterly results), with gross margin…
- 10-Q · November 6, 2025
- Nature's Sunshine reported Q3 net sales of $128,339,000 (up $13,724,000 or ~12.0% vs Q3 2024) with gross profit of $94,049,000 (gross margin ~73.3%) and diluted EPS of $0.30. Operating income rose to $8,975,000…
- 10-Q · July 31, 2025
- Nature’s Sunshine reported Q2 net sales of $114,750,000 (up from $110,551,000 in Q2 2024) and diluted EPS of $0.28 (vs $0.07 prior year), aided by a $3,026,000 foreign exchange gain. Gross profit was $82,299,000 (gross…
- 10-K · March 11, 2025
- Nature’s Sunshine positions itself as a natural health and wellness manufacturer and direct-selling company with a product line of over 800 SKUs sold through a global network of independent consultants across four…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing NATR makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever